Top

Published in:

01-12-2018 | Brief Report

Epidemiology, clinical and laboratory features of 24 consecutive cases of leptospirosis at a German infectious disease center

Authors: Thomas Theo Brehm, Julian Schulze zur Wiesch, Marc Lütgehetmann, Dennis Tappe, Philip Eisermann, Ansgar W. Lohse, Marylyn M. Addo, Stefan Schmiedel

Published in: Infection | Issue 6/2018

Abstract

To determine epidemiological, clinical and laboratory characteristics of leptospirosis, 24 consecutive patients diagnosed with the infection between 2011 and 2017 at the University Medical Center Hamburg-Eppendorf were retrospectively analyzed. The majority of patients were male travelers who returned from Southeast Asia and had a history of freshwater-associated activities. Considering the lack of discriminatory clinical or clinical chemistry parameters, leptospirosis should be regarded as differential diagnosis in any patient with acute febrile illness, especially with a history of travel to tropical and subtropical regions or freshwater exposure.

Adler B, de la Pena Moctezuma A. Leptospira and leptospirosis. Vet Microbiol. 2010;140:287–96. https://doi.org/10.1016/j.vetmic.2009.03.012.CrossRefPubMed

World Health Organization. Report of the second meeting of the leptospirosis burden epidemiology reference group. Geneva: World Health Organization; 2011. http://www.who.int/iris/handle/10665/44588. Accessed 16 July 2018.

World Health Organization. Human leptospirosis: guidance for diagnosis, surveillance and control. Geneva: World Health Organization. 2003. http://apps.who.int/iris/handle/10665/42667. Accessed 16 July 2018.

Robert Koch-Institut. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2016, Berlin 2017. https://www.rki.de/DE/Content/Infekt/Jahrbuch/Jahrbuch_2016.pdf?__blob=publicationFile. Accessed 16 July 2018.

Robert Koch-Institut. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2015, Berlin 2016. https://www.rki.de/DE/Content/Infekt/Jahrbuch/Jahrbuch_2015.pdf?__blob=publicationFile. Accessed 16 July 2018.

Robert Koch-Institut. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2014, Berlin 2015. https://www.rki.de/DE/Content/Infekt/Jahrbuch/Jahrbuch_2014.pdf?__blob=publicationFile. Accessed 16 July 2018.

Robert Koch-Institut. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2013, Berlin 2014. https://www.rki.de/DE/Content/Infekt/Jahrbuch/Jahrbuch_2013.pdf?__blob=publicationFile. Accessed 16 July 2018.

Robert Koch-Institut. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2012, Berlin 2013. https://www.rki.de/DE/Content/Infekt/Jahrbuch/Jahrbuch_2012.pdf?__blob=publicationFile. Accessed 16 July 2018.

Robert Koch-Institut. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2011, Berlin 2012. https://www.rki.de/DE/Content/Infekt/Jahrbuch/Jahrbuch_2011.pdf?__blob=. Accessed 16 July 2018.

10.

Brockmann SO, Ulrich L, Piechotowski I, Wagner-Wiening C, Nockler K, Mayer-Scholl A, et al. Risk factors for human Leptospira seropositivity in South Germany. Springerplus. 2016;5:1796. https://doi.org/10.1186/s40064-016-3483-8.CrossRefPubMedPubMedCentral

11.

Falldefinitionen des Robert. Koch-Instituts zur Übermittlung von Erkrankungs- oder Todesfällen und Nachweisen von Krankheitserregern. 2015.

12.

Stoddard RA. Detection of pathogenic Leptospira spp. through real-time PCR (qPCR) targeting the LipL32 gene. Methods Mol Biol (Clifton NJ). 2013;943:257–66. https://doi.org/10.1007/978-1-60327-353-4_17.CrossRef

13.

Hoffmeister B, Peyerl-Hoffmann G, Pischke S, Zollner-Schwetz I, Krause R, Muller MC, et al. Differences in clinical manifestations of imported versus autochthonous leptospirosis in Austria and Germany. Am J Trop Med Hygiene. 2010;83:326–35. https://doi.org/10.4269/ajtmh.2010.10-0040.CrossRef

14.

de Vries SG, Bekedam MMI, Visser BJ, Stijnis C, van Thiel P, van Vugt M, et al. Travel-related leptospirosis in the Netherlands 2009–2016: an epidemiological report and case series. Travel Med Infect Dis. 2018. https://doi.org/10.1016/j.tmaid.2018.05.002.CrossRefPubMed

15.

European Centre for Disease Prevention and Control. Leptospirosis - Annual Epidemiological Report 2016 [2014 data]. Annual Epidemiological Report on Communicable Diseases in Europe. 2017. https://ecdc.europa.eu/.en/publications-data/leptospirosis-annual-epidemiological-report-2016-2014-data. Accessed 16 July 2018.

16.

Jansen A, Stark K, Schneider T, Schoneberg I. Sex differences in clinical leptospirosis in Germany: 1997–2005. Clin Infect Dis. 2007;44:e69–72. https://doi.org/10.1086/513431.CrossRefPubMed

17.

Jansen A, Schoneberg I, Frank C, Alpers K, Schneider T, Stark K. Leptospirosis in Germany, 1962–2003. Emerg Infect Dis. 2005;11:1048–54. https://doi.org/10.3201/eid1107.041172.CrossRefPubMedPubMedCentral

18.

Lecour H, Miranda M, Magro C, Rocha A, Goncalves V. Human leptospirosis–a review of 50 cases. Infection. 1989;17:8–12.CrossRef

19.

Nardone A, Capek I, Baranton G, Campese C, Postic D, Vaillant V, et al. Risk factors for leptospirosis in metropolitan France: results of a national case–control study, 1999–2000. Clin Infect Dis. 2004;39:751–3. https://doi.org/10.1086/423272.CrossRefPubMed

20.

Katz AR, Ansdell VE, Effler PV, Middleton CR, Sasaki DM. Assessment of the clinical presentation and treatment of 353 cases of laboratory-confirmed leptospirosis in Hawaii, 1974–1998. Clin Infect Dis. 2001;33:1834–41. https://doi.org/10.1086/324084.CrossRefPubMed

21.

Vanasco NB, Schmeling MF, Lottersberger J, Costa F, Ko AI, Tarabla HD. Clinical characteristics and risk factors of human leptospirosis in Argentina (1999–2005). Acta Trop. 2008;107:255–8. https://doi.org/10.1016/j.actatropica.2008.06.007.CrossRefPubMed

22.

Crouzet J, Faucher JF, Toubin M, Hoen B, Estavoyer JM. Serum C-reactive protein (CRP) and procalcitonin (PCT) levels and kinetics in patients with leptospirosis. Eur J Clin Microbiol Infect Dis. 2011;30:299–302. https://doi.org/10.1007/s10096-010-1088-7.CrossRefPubMed

23.

Seguro AC, Lomar AV, Rocha AS. Acute renal failure of leptospirosis: nonoliguric and hypokalemic forms. Nephron. 1990;55:146–51.CrossRef

24.

Nakou K, Liamis G, Elisaf MS, Siamopoulos KC. Low normal potassium levels in acute renal failure: evidence of leptospirosis. Infection. 2000;28:196.CrossRef

25.

Weil A. Ueber eine eigentümliche, mit Milztumor, Icterus und Nephritis einhergehende, acute Infectionskrankheit. Dtsch Arch Klin Med. 1886;39:209.

26.

Plank R, Dean D. Overview of the epidemiology, microbiology, and pathogenesis of Leptospira spp. in humans. Microb Infect. 2000;2:1265–76.CrossRef

27.

Daher EF, Lima RS, Silva Junior GB, Silva EC, Karbage NN, Kataoka RS, et al. Clinical presentation of leptospirosis: a retrospective study of 201 patients in a metropolitan city of Brazil. Br J Infect Dis. 2010;14:3–10.CrossRef

28.

Johnson WD Jr., Silva IC, Rocha H. Serum creatine phosphokinase in leptospirosis. JAMA. 1975;233:981–2.CrossRef

29.

Trombert-Paolantoni S, Thomas P, Hermet F, Clairet V, Litou N, Maury L. [Leptospirosis screening: performance of the Serion Elisa Classic Leptospira IgM KIT]. Pathol Biol. 2010;58:95–9. https://doi.org/10.1016/j.patbio.2009.06.008.CrossRefPubMed

30.

Chen HW, Weissenberger G, Atkins E, Chao CC, Suputtamongkol Y, Ching WM. Highly sensitive loop-mediated isothermal amplification for the detection of Leptospira. Int J Bacteriol. 2015;2015:147173. https://doi.org/10.1155/2015/147173.CrossRefPubMedPubMedCentral

31.

Lourdault K, Matsunaga J, Haake DA. High-throughput parallel sequencing to measure fitness of Leptospira interrogans transposon insertion mutants during acute infection. PLoS Neglect Trop Dis. 2016;10:e0005117. https://doi.org/10.1371/journal.pntd.0005117.CrossRef

32.

Wilson MR, Naccache SN, Samayoa E, Biagtan M, Bashir H, Yu G, et al. Actionable diagnosis of neuroleptospirosis by next-generation sequencing. New Engl J Med. 2014;370:2408–17. https://doi.org/10.1056/NEJMoa1401268.CrossRefPubMed

33.

Guidugli F, Castro AA, Atallah AN. Antibiotics for treating leptospirosis. Cochrane Database Syst Rev. 2000. https://doi.org/10.1002/14651858.cd001306.CrossRefPubMed

Title: Epidemiology, clinical and laboratory features of 24 consecutive cases of leptospirosis at a German infectious disease center
Authors: Thomas Theo Brehm
Julian Schulze zur Wiesch
Marc Lütgehetmann
Dennis Tappe
Philip Eisermann
Ansgar W. Lohse
Marylyn M. Addo
Stefan Schmiedel
Publication date: 01-12-2018
Publisher: Springer Berlin Heidelberg
Published in: Infection / Issue 6/2018
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI: https://doi.org/10.1007/s15010-018-1181-x

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Epidemiology, clinical and laboratory features of 24 consecutive cases of leptospirosis at a German infectious disease center

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2018

Diagnosis of nontuberculous mycobacterial disease in the era of surveillance chest CT scans

Comparison of patient characteristics, clinical management, infectious specialist consultation, and outcome in men and women with methicillin-sensitive Staphylococcus aureus bacteremia: a propensity-score adjusted retrospective study

Bacteraemia post-autologous haematopoietic stem cell transplantation in the absence of antibacterial prophylaxis: a decade’s experience from Lebanon

Pyogenic brain abscess and subdural empyema: presentation, management, and factors predicting outcome

Resistance detection and re-treatment options in hepatitis C virus-related chronic liver diseases after DAA-treatment failure

Overuse of antimicrobials and over-hospitalization in an adult measles cluster in the Florence area during the ongoing Italian outbreak

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page